Top Social Impact Companies (5,502)

Market Expansion: National and payer footprint have broadened materially, with availability across all 50 states, plan relationships rising toward 100+, and sharp increases in providers, patients, and appointments. This widening reach indicates an ability to capture demand across geographies and insurance lines.

Investor Backing & Capital Strength: A $100M Series D at a roughly $2.3B valuation alongside substantial prior financing reflects strong access to growth capital. This position supports continued scaling of the network, product investments, and deeper insurer integrations.

Strong Revenue Growth: Revenue is described as having increased significantly over a recent 12‑month period, with earlier disclosures citing outsized year‑over‑year gains. Coupled with rising session volumes, this points to robust top‑line momentum despite limited public financial detail.

Strong Revenue Growth: Revenue is consistently rising at double-digit rates, including about 26% growth in 2025 and 22%–28% year-over-year gains across early 2026. Company disclosures also highlight increasing payers and monetization, reinforcing the revenue trajectory.

Market Expansion: International rollout accelerated across Europe and Latin America in 2025–2026, with entries into additional countries and leadership in downloads across several expansion markets. European expansion-market revenue rose sharply year over year, evidencing traction beyond core English-speaking geographies.

Strong Market Position & Advantage: The app maintains a top-tier standing among dating platforms, including #1 download positions in select European markets and a top-three rank in the U.S. Consistent MAU and payer growth alongside high download ranks indicate strengthening competitive footing.

Strong Revenue Growth: Revenue is described as having exceeded 40% year over year in 2022 and 273% growth over the Deloitte Fast 500 measurement period. Recent disclosures cite well over $100M in ARR and reporting of more than $100M in annual revenue.

Market Expansion: Customer footprint is reported at 3,500+ organizations across 150+ countries, with earlier periods adding 600+ customers and a London office opened to support rapid international growth. Partnerships and channel integrations are noted as expanding reach to multinational programs.

Product Line Growth: The platform has broadened through AI-powered launches (assistants, analytics, plan builders) and the acquisition of Pyrra to add social/digital threat intelligence. Continued investment in 2026, including new leadership roles focused on AI, underscores ongoing product expansion.

Strong Market Position & Advantage: Scale of 290M+ learners and 12k–18k enterprise customers following the May 2026 combination signals a top-tier position in online learning. The combined platform also cites 95,000 creators and more than $1.5B of 2025 revenue, reinforcing competitive heft.

Strong Revenue Growth: Coursera delivered 9% revenue growth in 2025 and, after the Udemy combination, reported Q2 2026 revenue rose about 60% year over year. Management also raised full‑year 2026 reported revenue guidance to $1.220–$1.245 billion.

Diversified Revenue Streams: Multiple engines—consumer, enterprise, and subscriptions—are contributing, with Coursera’s consumer (+10%) and enterprise (+7%) segments growing in 2025. Udemy’s subscriptions (+8%) and Udemy Business revenue (+6%) expanded even as its consumer marketplace declined.

Strong Revenue Growth: Revenue is characterized as surging, with a high placement on the 2026 Inc. 5000 list for multi‑year expansion. Company materials also state revenue has doubled or tripled annually across its history, though these figures are not from audited financials.

Investor Backing & Capital Strength: Capital resources appear substantial, with more than $100M raised and a Series C closed in April 2025. Prominent venture backing and stated plans for continued hiring support capacity to fund scale.

Market Expansion: Operating footprint is described as broadening, with 1,000+ clients served daily and 100,000+ annually, and expansion beyond Social Security Disability into workers’ compensation. The lawyer network grew from 30 to 86 partner firms, indicating wider coverage and capacity.

Market Expansion: District reach has expanded from 1,000+ around the 2021 acquisition to 1,900+ by early 2026, with coverage across 50+ states and over half of U.S. EL students. This indicates broadening geographic penetration and customer footprint.

Product Line Growth: The offering has evolved from EL program management and instructional tools into a unified ELD platform that now includes benchmark assessment via the 2026 Ellevation Benchmark launch. This broader scope points to increased relevance and potential expansion within existing districts.

Strong Market Position & Advantage: The company is frequently described as a leading, specialized provider in its EL/MLL niche, serving 1,900+ districts and 2.5M+ learners. Such penetration suggests a defensible position within its targeted category.

Strong Revenue Growth: Inclusion on the Inc. 5000 list in both 2025 and 2026 is cited as direct evidence of multi‑year revenue growth. Consecutive recognition implies sustained top‑line expansion over the measured period.

Market Expansion: Partner counts rose from about 140+ colleges and universities across 33 states in 2025 to 160–180+ partners across 34 states by 2026. New statewide and institutional engagements in places such as Michigan, New Jersey, Massachusetts, and additional colleges indicate a widening geographic footprint.

Strategic Partnerships: State‑level programs (for example, New Jersey’s statewide re‑enrollment marketplace and Michigan’s multi‑institution initiative) show deepening relationships beyond single campuses. Ongoing additions like Montgomery County Community College and Mineral Area College reflect continued partner acquisition.

Strong Revenue Growth: Independent estimates indicate revenue roughly doubled in 2024 to around $471M annualized, pointing to rapid top-line expansion. While privately held and unaudited, the trajectory across 2023–2025 is characterized by accelerated scaling.

Market Expansion: Covered therapy was extended to all 50 states plus Washington, D.C. in 2024, with psychiatry rolled out nationwide by 2025. The network grew from 10,000+ providers in 2024 to 23,000+ by 2026, broadening reach and utilization.

Strategic Partnerships: An Amazon Health program listing and other distribution channels increased visibility and access. A cited OptumCare collaboration saw referrals grow by triple digits year over year, signaling traction in enterprise pathways.

Market Expansion: Operations span numerous U.S. cities and key European hubs, and examples such as multi-location laptop programs and a CETF-supported initiative point to activity at broader geographic scale.

Product Line Growth: The offering has evolved into a software-enabled hardware-lifecycle platform with asset tracking, reporting, and APIs, alongside expanded device retrievals covering laptops, phones, tablets, and monitors. This broadening increases addressable use cases.

Strategic Partnerships: Documented collaborations include a CETF–Revivn program cited by the California Public Utilities Commission and large-scale work with Block to repurpose thousands of laptops across global sites. These relationships extend reach and validate operational scale.

Market Expansion: The platform’s footprint expanded from 400 participating sites in 2022 to 6,000+ sites by 2026, with presence across 50+ countries and 25+ sponsors. Evidence indicates marketplace adoption more than doubled in 2023 and activity surpassed 100 trials by 2024.

Product Line Growth: The offering broadened from a marketplace into AI-powered patient pre-screening and integrated workflows, with reported operational time savings and enrollment improvements in case studies. Subsequent integrations with CRIO, RealTime eClinical, and eClinPro signal continued platform expansion.

Strategic Partnerships: Relationships include major pharmaceutical organizations (e.g., 16 of the top 30 in 2024 and now 25+ sponsors) and ecosystem deals such as RealTime eClinical (50+ networks representing 2,000+ sites) plus CRIO/eClinPro integrations. These ties appear to extend distribution and enrich data used for site selection and enrollment.

Investor Backing & Capital Strength: Institutional investors are providing sustained backing—Partners Group took a significant minority stake in 2022 alongside CVC Growth—with an explicit plan to fund international expansion, new products, and strategic acquisitions. This capital availability signals resources to underwrite the next phase of growth.

Product Line Growth: The company has expanded beyond chemical management into safety, ergonomics, industrial hygiene, operational risk, environmental compliance, ESG, and AI. Recent 2026 launches and new AI capabilities demonstrate continued broadening of the platform and addressable market.

Strong Market Position & Advantage: Independent industry recognition repeatedly places the firm in leadership cohorts (e.g., Verdantix Green Quadrant and G2 category leader listings). A large installed base—spanning 10M+ users and 15,000–19,000 customers across reported periods—reinforces competitive positioning.

Market Expansion: Student enrollment and institutional footprint are expanding across more colleges and regions, including new regional hubs and statewide collaborations. Geographic initiatives in places such as South Florida and Charlotte illustrate deeper local ecosystems forming with universities, employers, and funders.

Strategic Partnerships: High-profile collaborations and grants—such as with Anthropic, Google.org, and Wells Fargo—signal widening institutional and employer alliances that enable program expansion. Partner activity spans AI curriculum integration and regional investments, indicating durable ecosystem support.

Cost & Operational Efficiency: The organization reports lowering delivery cost per student while increasing the number of students served. This suggests scale is being achieved alongside improving unit economics rather than purely through higher spend.

Profitability: Earnings are characterized as record in 2025 with further year-over-year gains into the first half of 2026, indicating improved bottom-line strength. Profit growth is highlighted alongside higher operating income and strong net income trends.

Strong Revenue Growth: Revenue is increasing on a multi-year basis, with 2025 at a record and both Q1 and Q2 2026 marking record quarters despite uneven quarterly momentum. Guidance still points to higher full-year revenue versus 2025.

Future-Ready Strategy: Management is pursuing a bank acquisition and new product expansion to broaden the platform and support future growth. Updates to underwriting models are also emphasized to improve risk management and operational scalability.

Product Line Growth: Newer businesses such as Pharma Direct and subscriptions are expanding rapidly, with clear momentum highlighted in 2026. Investment is being shifted toward these lines to replace slower legacy revenue.

Future-Ready Strategy: Management is prioritizing Pharma Direct and subscription products and raised 2026 revenue guidance, signaling a transition aimed at restoring overall growth. These segments are described as the main engines expected to offset declines in the legacy business.

Profitability: Profitability remains solid even as the top line fluctuates, including positive GAAP earnings and substantial adjusted EBITDA in Q2 2026. Operating cash flow also strengthened, supporting continued execution.

Strong Revenue Growth: TechCrunch reported that revenue increased six-fold year over year as of May 2025, indicating rapid top-line acceleration.

Market Expansion: The company expanded from 5 states in 2023 to 18 states in 2025 and announced nearly 25 states by February 2026, pointing to broadening geographic coverage.

Investor Backing & Capital Strength: The company closed a $55 million Series B in May 2025, bringing total funding to about $125 million. The round was led by General Catalyst with participation from Andreessen Horowitz, GV, and Accel, underscoring access to capital.

Strong Revenue Growth: Revenue is rising sharply, with Q2 2026 at about $71M (+37% YoY) and H1 2026 at $138.8M versus $83.8M in the comparable 2025 period. Sequential gains from late 2025 into 2026 reinforce the growth trajectory.

Profitability: Segment profitability is evident, including roughly $22.9M adjusted EBITDA in Q1 2026 and reported net earnings in 2025. Management guidance pointing to $50–$60M of adjusted EBITDA for 2026 suggests scale efficiencies are emerging.

Strong Market Position & Advantage: Scale and positioning are reinforced by 1.6–1.7 million paying subscribers, rising ARPU, and operation as Upbound’s fastest-growing segment. The acquisition and dedicated segment reporting underscore strategic relevance and competitive standing.

Strong Market Position & Advantage: As one of the 12 Reserve Banks with FOMC participation and nationally followed indices like CFNAI and NFCI, the institution maintains a prominent role in U.S. central banking and research. Materials also highlight influential convenings and system responsibilities that reinforce this position.

Product Line Growth: The introduction of the Chicago Fed Labor Market Indicators in September 2025 added a twice‑monthly data release with real‑time unemployment forecasts, hiring measures, and layoff/separation metrics. This expands recurring research/data offerings beyond maintaining existing outputs.

Resilient & Sustainable Growth: Operating evidence shows modest increases in expenses and compensation alongside continued publications, events, and regional analysis, indicating stable ongoing operations. Financial statements also note a larger 2025 balance sheet while the organization remains active across supervision, payments, and research.

Market Expansion: Geographic reach is described as nationwide through Medicare, with pages indicating coverage in 48 to all 50 states, signaling active expansion. State-by-state therapist listings and nationwide positioning reinforce a broad and growing footprint.

Product Line Growth: Service scope expanded from therapy for older adults to a broader platform that includes behavioral health, advocacy, wellness classes, mind exercises, and AI care agents. This indicates growth beyond the original core offering.

Strong Hiring & Retention: Headcount and hiring activity are depicted as rising quickly, with quarter-over-quarter increases reported by company intelligence trackers and ongoing recruiting across clinical and corporate roles. This workforce build-out supports scaling operations.

Strong Revenue Growth: ARR is reported to have doubled over the prior year and to be on track for at least another doubling, with profitability cited before the Series A. Hiring alongside revenue growth is described, reinforcing momentum.

Product Line Growth: The platform has expanded beyond basic communications into billing, payroll, enrollment, reporting, subsidy management, and AI tools such as Camber. Current product pages reflect a substantially broader offering than the original scope.

Market Expansion: The company states it serves 5,000+ childcare programs and 500,000+ owners, directors, teachers, and families across all 50 states, and a September 2026 acquisition by Procare underscores expanded reach within the category. Earlier usage metrics and ongoing hiring further illustrate scaling activity.

Strong Revenue Growth: Revenue is reported to have risen from 2024 to 2025, with an annualized run rate later surpassing the $125–$130 million range. This momentum is highlighted alongside increases in customer usage and overall scale.

Profitability: The company achieved its first annual net profit (around $3 million), indicating healthier unit economics and improving financial stability. This marks a shift from earlier periods focused on rebuilding.

Market Expansion: Operations expanded into 19 new states in 2025, bringing total coverage to roughly 33–34 states. New offerings such as Possible Advance further extended product reach and addressable market.